MANHARD KIMBERLY — SEC insider filings
SEC reporting owner CIK 1202094. 28 insider filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 28 filings on record, filed 2020-08-21 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 10,000 shares, $139,800 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 15,533 shares, $513,172 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 66.
- Largest priced transaction: sale of 10,000 shares @ $20.00 ($200,000) in HERON THERAPEUTICS, INC. /DE/, filed 2020-12-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | Director | 7 | 1 leg · 10,000 sh · $139,800 | 5 legs · 2,500 sh · $279,010 | 4 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Drug Development | 16 | — | 3 legs · 13,033 sh · $234,162 | 53 |
| Inhibrx, Inc. (INBX) | Director | 5 | — | — | 9 |
Insider filings — MANHARD KIMBERLY
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4/A | Inhibrx Biosciences, Inc. (INBX) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-09-15 | 4 | Inhibrx Biosciences, Inc. (INBX) | Sale (S): 500 @ $111.78 · Sale (S): 500 @ $110.26 · Sale (S): 500 @ $105.05 | EDGAR |
| 2026-09-10 | 4 | Inhibrx Biosciences, Inc. (INBX) | Sale (S): 500 @ $115.14 · Sale (S): 500 @ $115.80 | EDGAR |
| 2026-06-04 | 4 | Inhibrx Biosciences, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Inhibrx Biosciences, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4 | Inhibrx Biosciences, Inc. (INBX) | Purchase (P): 10,000 @ $13.98 | EDGAR |
| 2024-05-30 | 4 | Inhibrx Biosciences, Inc. (INXB) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Inhibrx, Inc. (INBX) | Disposition to issuer (D): 3,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 17,259 (derivative) | EDGAR |
| 2023-05-30 | 4 | Inhibrx, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2023-04-17 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 1,417 @ $2.88 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 149,365 (derivative) @ $0 | EDGAR |
| 2023-01-17 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Other (J): 1,655 @ $3.27 · Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $3.17 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2022-10-17 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $3.76 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2022-07-27 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 165,961 (derivative) @ $0 | EDGAR |
| 2022-07-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $3.01 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2022-05-26 | 4 | Inhibrx, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-05-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Other (J): 1,504 @ $3.84 · Sale (S): 1,504 @ $4.76 | EDGAR |
| 2022-04-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $6.07 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2022-01-14 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $8.30 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2021-10-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Tax withholding (F): 433 @ $10.55 · Option exercise (M): 1,250 (derivative) @ $0 · Grant/award (A): 92,200 (derivative) @ $0 · Grant/award (A): 55,320 (derivative) @ $0 | EDGAR |
| 2021-07-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Tax withholding (F): 433 @ $13.48 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2021-06-08 | 4 | Inhibrx, Inc. (INBX) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2021-05-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Other (J): 1,529 @ $13.90 · Sale (S): 1,529 @ $17.66 | EDGAR |
| 2021-04-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Tax withholding (F): 433 @ $16.66 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2021-01-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Tax withholding (F): 433 @ $18.16 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2020-12-23 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 10,000 @ $13 · Sale (S): 10,000 @ $20 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2020-10-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 120,000 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2020-08-21 | 4 | Inhibrx, Inc. (INBX) | Grant/award (A): 17,259 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1202094 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs